Skip to content
healthcare.dev

neomycin sulfate, polymyxin b sulfate and dexamethasone

NDC 69918-515, neomycin sulfate, polymyxin b sulfate and dexamethasone, suspension, from Nordic Pharma, Inc..

Product NDC
69918-515
Status
Listed
Labeler
Nordic Pharma, Inc.
Dosage form
SUSPENSION
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA050023
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69918-515 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOMYCIN SULFATE3.5 mg/mL
  • POLYMYXIN B SULFATE10000 [USP'U]/mL
  • DEXAMETHASONE1 mg/mL

Pharmacologic classes

Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]

Package NDCNDC-11Package
69918-515-05699180515055 mL in 1 BOTTLE, PLASTIC (69918-515-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/191c1a56-194f-4876-b501-2f8aee447d83
  • NADAC price for package 69918051505

    GET /v1/drugs/nadac/69918051505

Use it

Look up 69918-515 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69918-515 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69918-515. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.